Announced Tue, 16 Jun · 10:08 IST
Japanese patent granted for cancer treatment compound
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹284.50
prior close
₹307.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.5-2.0-2.1+4.0+4.0+3.7+3.5+0.2-0.9-8.3-8.6——
Up moveDown movePending
AI summary
The Japanese Patent Office granted Godavari Biorefineries a patent for '5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer.' The patent covers novel compounds that show strong inhibitory effects on cancer and cancer stem cells, particularly breast and prostate cancer. Patent was registered on May 26, 2026; original application was filed on October 26, 2021.
Likely market impact
Strengthens the company's IP portfolio in oncology; a positive long-term signal, though no immediate revenue impact.